Formerly doing business as Helix Interational Corporation located in BatonRouge LA, Helix BioMedix, Inc. is a late-stage biotechnology company that has a portfolio of issued patents that covers six distinct classes of peptides, covering over 1 million unique peptide sequences. The company's mission is to become the industry leader in developing and commercializing small proteins known as bioactive peptides. The antimicrobial and wound healing properties of these peptides qualify them for inclusion in a wide range of both pharmaceutical and consumer products. The company is currently focused on the development of selected peptides as topical anti-infectives and in wound healing. Non-pharmaceutical applications being pursued by Helix BioMedix include adjuvants for cosmetics/cosmeceuticals, personal care, plant health, animal health and wide-spectrum biocides. The company offers small proteins known as bioactive peptides. Its uses include anti-aging skin care, acne treatment, wound healing, and treatment of athlete's foot and other fungal infections of the skin and hair, including the management of various dermatoses. Helix BioMedix also develops peptides in various therapeutic and industrial product categories, such as oral care, biocides, and animal health.